ReviewMolecules (Basel, Switzerland)2025
Chitosan as an Elicitor in Plant Tissue Cultures: Methodological Challenges.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Comparative Effects of High-Molecular-Weight Chitosan and Chitosan Oligosaccharide Lactate on Metabolic Adjustment and Salinity Tolerance inMolecules (Basel, Switzerland) · 2026Article
- Elicitor-Mediated Enhancement of Secondary-Metabolite Biosynthesis inPlants (Basel, Switzerland) · 2026Review
- Current Regulatory Frameworks for Bioactive Inputs in Plant Systems Producing Pharmaceutically Important Compounds.Plants (Basel, Switzerland) · 2026Review
- Combined Application of Chitosan-InducedFoods (Basel, Switzerland) · 2026Article
- Nano-Elicitation Approaches for Boosting Secondary Metabolites in Medicinal Plant Cell Cultures.Plants (Basel, Switzerland) · 2025Review
- Hybrid Poly(Lactic)-Chitosan Scaffold Intensifying In Situ Bioprocessing ofInternational journal of molecular sciences · 2025Article
- New Chlormequat-Based Ionic Liquids as Plant Resistance Inducers.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitosan (CTS) is a biodegradable and biocompatible biopolymer derived from chitin. Thanks to its diverse biological activities and environmentally friendly nature, it has emerged as a promising agent in plant tissue culture. Recent studies have highlighted its role as a natural elicitor that can enhance plant growth, seed germination, and the biosynthesis of secondary metabolites in vitro. In plant tissue culture, it acts as a biotic elicitor, mimicking a pathogen attack and activating the pathogenesis-related proteins to induce secondary metabolite production. In vitro tissue culture is a scientifically meaningful and cost-effective approach to testing the elicitation mechanisms of various abiotic elicitors, including CTS. However, the methodology of CTS elicitation in plant tissue cultures is not straightforward or uniform due to the differences in the CTS origin, molecular weight, and degree of deacetylation, all of which directly affect solubility. This review summarizes the methodological approaches to the use of CTS in plant tissue culture elicitation and highlights specific features of these procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.